Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Stephanie R Reading"'
Autor:
Stephanie R. Reading, Mary Helen Black, Daniel E. Singer, Alan S. Go, Margaret C. Fang, Natalia Udaltsova, Teresa N. Harrison, Rong X. Wei, In-Lu Amy Liu, Kristi Reynolds, for the ATRIA-CVRN Investigators
Publikováno v:
BMC Cardiovascular Disorders, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background Atrial fibrillation (AF) patients are routinely prescribed medications to prevent and treat complications, including those from common co-occurring comorbidities. However, adherence to such medications may be suboptimal. Therefore
Externí odkaz:
https://doaj.org/article/b9ceebcf90164201a19594fc5ccaf306
Autor:
Gloria C. Chi, Michael H. Kanter, Bonnie H. Li, Lei Qian, Stephanie R. Reading, Teresa N. Harrison, Steven J. Jacobsen, Ronald D. Scott, Jeffrey J. Cavendish, Jean M. Lawrence, Sara Y. Tartof, Kristi Reynolds
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 5 (2020)
Background Trends in acute myocardial infarction (AMI) incidence rates for diverse races/ethnicities are largely unknown, presenting barriers to understanding the role of race/ethnicity in AMI occurrence. Methods and Results We identified AMI hospita
Externí odkaz:
https://doaj.org/article/1988d162274c4808bb84b31866d04090
Autor:
Robert S. Rosenson, Demetria Hubbard, Keri L. Monda, Stephanie R. Reading, Ligong Chen, Paul J. Dluzniewski, Greer A. Burkholder, Paul Muntner, Lisandro D. Colantonio
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 1 (2020)
Background In the 2000s, adults with HIV had a higher risk for atherosclerotic cardiovascular disease (ASCVD) compared with those without HIV. There is uncertainty if this excess risk still exists in the United States given changes in antiretroviral
Externí odkaz:
https://doaj.org/article/fc110e86a996431b8e5b106f2a2037ec
Autor:
Vera Bittner, Emily C. McKinley, Michael E. Farkouh, Stephanie R. Reading, Ligong Chen, Emily B. Levitan, Jason Exter, Monika M. Safford, Lei Huang, Robert S. Rosenson, Kate K. Orroth, Mark Woodward, Lisandro D. Colantonio, Elizabeth A. Jackson, Todd M. Brown, Paul Muntner
Publikováno v:
Cardiovascular Drugs and Therapy. 37:107-116
Adults with atherosclerotic cardiovascular disease (ASCVD) are recommended high-intensity statins, with those at very high risk for recurrent events recommended adding ezetimibe and/or a proprotein convertase subtilisin/kexin type 9 inhibitor if thei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee90307815361c52d9d69f4f1a274ff0
https://doi.org/10.1007/s10557-021-07268-x
https://doi.org/10.1007/s10557-021-07268-x
Autor:
Stephanie R. Reading, PhD, MPH, Kimberly R. Porter, PhD, MPH, Jeffrey M. Slezak, MS, Teresa N. Harrison, SM, Joy S. Gelfond, Gary W. Chien, MD, Steven J. Jacobsen, MD, PhD
Publikováno v:
Sexual Medicine, Vol 5, Iss 4, Pp e219-e228 (2017)
Introduction: Many men diagnosed with prostate cancer are concerned with how the disease and its course of treatment could affect their health-related quality of life (HRQOL). To aid in the decision-making process on a course of treatment and to bett
Externí odkaz:
https://doaj.org/article/44263b4ca4544cdda652546a97bbd6b2
Autor:
Stephanie R. Reading, Alan S. Go, Margaret C. Fang, Daniel E. Singer, In‐Lu Amy Liu, Mary Helen Black, Natalia Udaltsova, Kristi Reynolds
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 4 (2017)
BackgroundAtrial fibrillation (AF) is the most common clinically significant arrhythmia in adults and a major risk factor for ischemic stroke. Nonetheless, previous research suggests that many individuals diagnosed with AF lack awareness about their
Externí odkaz:
https://doaj.org/article/25c4b77841ea489a8a5d0649d56ff1e5
Autor:
Sara N Levintow, Stephanie R Reading, Sina Noshad, Sophie E Mayer, Catherine Wiener, Bassim Eledath, Jason Exter, M Alan Brookhart
Publikováno v:
Clinical Epidemiology.
Sara N Levintow,1,2 Stephanie R Reading,3 Sina Noshad,3 Sophie E Mayer,1,2 Catherine Wiener,1 Bassim Eledath,1 Jason Exter,3 M Alan Brookhart1,4 1NoviSci, Inc., Durham, NC, USA; 2Department of Epidemiology, University of North Carolina at Chapel Hill
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c22ba9f556e85932412d03be319d77bf
https://www.dovepress.com/lipid-testing-trends-before-and-after-hospitalization-for-myocardial-i-peer-reviewed-fulltext-article-CLEP
https://www.dovepress.com/lipid-testing-trends-before-and-after-hospitalization-for-myocardial-i-peer-reviewed-fulltext-article-CLEP
Autor:
M. Alan Brookhart, Diane Reams, Kiran Philip, Leah J. McGrath, Paul J. Dluzniewski, Ying Yu, Sara N. Levintow, Bradley Saul, Stephanie R. Reading
Publikováno v:
Clinical Epidemiology. 12:835-845
Background The 2013 ACC/AHA cholesterol treatment guidelines removed the recommendation to treat adults at risk of cardiovascular disease to goal levels of low-density lipoprotein cholesterol (LDL-C). We anticipated that the frequency of LDL-C testin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe50718093ac2d18439b6ab54adb7e37
https://doi.org/10.2147/clep.s259757
https://doi.org/10.2147/clep.s259757
Autor:
Sheila M Manemann, Sarah Cohen, Stephanie R Reading, Sina Noshad, Naimisha Movva, Susan Weston, Jill Killian, Alanna Chamberlain
Publikováno v:
Circulation. 145
Background: Among patients who experience a myocardial infarction (MI), elevated low-density lipoprotein cholesterol (LDL-C) is a major risk factor for experiencing a subsequent cardiovascular (CV) event; however, real-world evidence is lacking in re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3694a75d7f04f777f2982611d7bec081
https://doi.org/10.1161/circ.145.suppl_1.p125
https://doi.org/10.1161/circ.145.suppl_1.p125
Autor:
Emily C, McKinley, Vera A, Bittner, Todd M, Brown, Ligong, Chen, Jason, Exter, Michael E, Farkouh, Lei, Huang, Elizabeth A, Jackson, Emily B, Levitan, Kate K, Orroth, Stephanie R, Reading, Robert S, Rosenson, Monika M, Safford, Mark, Woodward, Paul, Muntner, Lisandro D, Colantonio
Publikováno v:
Cardiovascular drugs and therapy.
Adults with atherosclerotic cardiovascular disease (ASCVD) are recommended high-intensity statins, with those at very high risk for recurrent events recommended adding ezetimibe and/or a proprotein convertase subtilisin/kexin type 9 inhibitor if thei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c00ac6a5dc32ad12c85f4577176088a8
https://pubmed.ncbi.nlm.nih.gov/34599698
https://pubmed.ncbi.nlm.nih.gov/34599698